Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A et al
PMID: 25230094
The Fecal Microbiota Transplantation to Improve Efficacy of Immune Checkpoint Inhibitors in Renal Cell Carcinoma (TACITO, NCT04758507) 52 study is an investigator-initiated, randomized, double-blind, placebo-controlled phase 2a clinical trial designed to determine whether donor FMT from complete ICI responders can enhance the effectiveness of first-line pembrolizumab plus axitinib therapy in patients with mRCC
A Market in Rapid Expansion The regulatory crackdown comes against the backdrop of explosive growth in India's GLP-1 drug market
The Bigger Picture: Rethinking Addiction at the Molecular Level What makes the GLP-1 story so significant is what it reveals about addiction itself
US$ 27.70
US$ 28.30
US$ 29.45
US$ 25.90
US$ 20.30
US$ 23.69
US$ 24.79
US$ 24.95
US$ 22.05
